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Purpose. A common pediatric dilemma involves management of children with recurrent febrile urinary tract infections (UTIs)
who have normal voiding cystourethrograms. Vesicoureteral reﬂux (VUR) has been demonstrated in such cases by performing
a cystogram which positions the instillation of contrast (PIC) at the ureteral oriﬁce. We describe the evidence supporting this
diagnostic test. Materials and Methods. The literature was searched to identify and subsequently evaluate all studies investigating
PIC cystography. Results. In patients with febrile UTIs and negative VCUGs, the PIC cystogram has been demonstrated to identify
occult reﬂux (PIC-VUR). When identiﬁed and treated, these patients have a signiﬁcant reduction in the incidence of febrile UTIs.
Conclusions. Although the current literature on PIC cystography is limited, it appears to be a clinically useful test in a select group
of patients with recurrent febrile UTIs, that are not found to have VUR on a conventional VCUG. A prospective randomized trial
is underway to further deﬁne its role in the treatment algorithm of febrile UTIs.
Copyright © 2008 Jennifer A. Hagerty et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
UTIs result in over 1 million physician visits annually,
aﬀecting from 2.4% to 2.8% of children. Reference [1]M a n y
of these patients will go on to have recurrent infections.
Reference [1] Recurrent febrile UTIs, while not a proven
risk for renal damage, contribute to economic burdens for
the family and society because of the recurrent medical
needs and hospitalizations. Inpatient hospital costs alone are
estimated to be greater than 180 million dollars per year [1].
These ﬁgures do not consider the societal impact of such
UTIsondayschildrenlosefromschoolorparentsmisswork.
Less than 50% of patients with febrile UTIs demonstrate
VUR. Despite an adequate work up to include charac-
terization of the type and source of bacteria, upper tract
evaluationtoincluderenalultrasoundandDMSArenogram,
and lower tract evaluation to include voiding cystography
and diagnosis of dysfunctional elimination syndrome (DES),
the etiology of recurrent febrile UTIs often remains elusive.
The empiric management of these patients often involves
administering antimicrobials intermittently when infections
occur or chronically as prophylaxis.
Because we have been dissatisﬁed with such empiric
management, we have pursued further testing for reﬂux
in such patients with recurrent febrile UTIs who show no
evidence of reﬂux on a conventional VCUG. This testing
is known as the positioned instillation of contrast (PIC)
cystogram. This is done during cystoscopy by positioning
the instillation of contrast at the ureteral oriﬁce under
ﬂuoroscopic control. This is a test to check for VUR that
may be clinically signiﬁcant yet was not identiﬁed on the
conventional VCUG. The historical evolution of this test
was based upon observations that many of these children
were found to have patulous oriﬁces that easily distended
with the ﬂow of water (i.e., hydrodistention) when they were
evaluated endoscopically. Noted hydrodistention was then
followed by checking for VUR using radiographic contrast
ﬂuid. As the reﬂux was demonstrated on PIC, but not
by conventional VCUG, it is termed occult. We detail the
current knowledge regarding the test and our view on its2 Advances in Urology
place in the current management scheme of children with
recurrentfebrileUTIswhodonothaveVURonconventional
VCUG.
2. PIC CYSTOGRAPHY TECHNIQUE
PIC cystography is performed at the time of cystoscopy.
After induction of general anesthesia, the child is placed in
the dorsal lithotomy position. Using a rigid cystoscope, the
urethra and bladder are systemically evaluated for anatom-
ical abnormalities such as ureteroceles, diverticuli, and
mucosal abnormalities. The ureteral oriﬁces are identiﬁed
andevaluatedfortheirpositionandtrigonalappearance.The
ureteral oriﬁces are then evaluated for insuﬃciency, VUR, as
follows:
(i) the bladder is emptied,
(ii) the cystoscope beak is positioned facing the ureteral
oriﬁce, close enough to the ureteral oriﬁce so that the
oriﬁce ﬁlls the cystoscopic view but not inside the
oriﬁce,
(iii) contrast to be instilled is placed at a height of 1 meter
above the level of the bladder. This is the height of
contrast ﬂow done for a conventional VCUG,
(iv) via the irrigation port of the cystoscope, contrast is
ﬂowed toward the ureteral oriﬁce while ﬂuoroscopy
is done,
(v) the bladder is then emptied and the procedure is
repeated on the contralateral side [2].
If the ureteral oriﬁce is insuﬃcient to prevent reﬂux of
contrast, hydrodistention will be noted at cystoscopy and
VUR will be imaged by ﬂuoroscopy.
3. PILOT STUDIES ON PIC CYSTOGRAPHY
In 2003, Rubenstein et al. introduced the technique and
their experience in using this test. Fifty seven children who
underwentcystoscopywereevaluated.Thedatawasanalyzed
by comparing the results in a control group versus those in
the study group. The control group was comprised of 2 sets
of patients: (a) patients not expected to demonstrate VUR
as there was not a history of febrile UTI, the ultrasound
was normal, and the conventional VCUG was normal (15
patients, 30 ureteral oriﬁces) and (b) patients expected
to demonstrate VUR on a PIC cystogram as there was a
history of febrile UTI and VUR was seen on conventional
VCUG (12 patients, 24 ureteral oriﬁces). The study group
was comprised of patients with recurrent febrile UTIs, a
normal ultrasound, and a normal VCUG (30 patients, 60
oriﬁces) [2]. The analysis of data for the control group
(a) in which all patients were not expected to demonstrate
VUR demonstrated that all oriﬁces appeared normal and
none demonstrated PIC-VUR. In the analysis of data for
the control group (b) in which all patients had VUR on
conventionalVCUG,all15ureteraloriﬁceswithknownVUR
showed lateral ectopia and/or patulous morphology, and
hydrodistention and also demonstrated PIC-VUR. A total of
four ureteral oriﬁces appeared normal and did not exhibit
VUR by VCUG or PIC cystography,and5 werelateraland/or
patulous and did not demonstrate VUR by VCUG but did
show PIC-VUR. From this data, Rubenstein concluded that
PIC cystography was 100% sensitive and 91% speciﬁc in
identifying VUR [2]. These ﬁndings in the control group
are very important since this demonstrates that a patient
with a normal oriﬁce will not artifactually reﬂux with PIC
cystography.
In the study group, all 30 patients had at least one
oriﬁce with abnormal morphology. PIC-VUR was identiﬁed
in all these patients with a history of febrile UTIs. All
were treated for VUR with either antimicrobial prophylaxis
or reimplantation. During 8-month followup, no patients
experienced a recurrent febrile UTI [2].
Morerecently,Tareenetal.performedasimilarstudyina
small number of patients resulting in their recommendation
that the PIC cystogram should be part of the algorithm in
evaluating patients with recurrent febrile UTIs without VUR
on VCUG. All 5 patients in this study with radiographic
conﬁrmation of pyelonephritis showed PIC-VUR. All were
treatedwithendoscopicinjectionofdextranomer/hyaluronic
acid copolymer or vesicoureteral reimplantation. In a fol-
lowup from 11 to 16 months, no patient has had recurrence
of febrile UTIs [3].
From these initial reports, it is concluded that occult
VUR identiﬁed by PIC cystography may provide an expla-
nation for recurrent febrile UTIs in patients with otherwise
negative radiographic studies.
4. MULTI-INSTITUTIONAL EVALUATION OF
PIC CYSTOGRAPHY
These initial experiences with treatment of VUR demon-
strated by PIC cystography for febrile UTIs sparked the
establishment of a multi-institutional registration of cases
by Edmondson et al. [4]. Four centers performed PIC
cystography on 39 consecutive patients with febrile UTIs
and negative VCUGs. PIC-VUR was identiﬁed in 82% of
the patients with febrile UTIs and negative VCUGs. A
strong correlation between the ureteral oriﬁce appearance,
hydrodistention and the presence of VUR was identiﬁed.
If the oriﬁce was patulous, it was 38 times more likely to
demonstrate VUR. Laterally displaced oriﬁces were 9 times
more likely to demonstrate VUR. Also 100% of oriﬁces that
hydrodistended were positive for VUR [4].
This multi-institutional registry demonstrated a similar
and reproducible incidence of PIC-VUR in patients with
recurrent febrile UTIs as Rubenstein’s inaugural study. The
study also further established a correlation between oriﬁce
location and morphology.
5. CLINICAL IMPORTANCE OF PIC CYSTOGRAPHY
To further examine whether PIC-VUR is simply a radio-
graphic observation or an entity with clinical relevance, the
following studies were performed.
Hagerty and the PIC Cystography Group concluded that
PIC-VUR is clinically signiﬁcant by determining that theJennifer A. Hagerty et al. 3
incidence rate of febrile UTI is lowered signiﬁcantly by
treatment of VUR identiﬁed by PIC. 14 centers enrolled
118 patients with recurrent febrile UTIs, who demonstrated
PIC-VUR. Patients were treated with underwent endoscopic
injection (104), ureteral reimplantation (3), or antimicrobial
prophylaxis (11). Overall, the incidence rate for febrile UTI
decreased signiﬁcantly from 0.16 per case/mo before PIC-
VUR treatment to 0.008 per case/mo after treatment. The
post treatment rate of febrile UTI in cases treated with
antibiotic versus surgery was not signiﬁcantly diﬀerent [5].
Noe and Williams also described their experience with
PIC cystography and simultaneous dextranomer/hyaluronic
acid copolymer injection in 47 children with a history of
pyelonephritis and negative VCUG. Success was deﬁned as
no further febrile UTIs. Repeated VCUGs were not per-
formed as in the prior studies, as they were negative prior to
treatment. A total of 75% of the patients had PIC-VUR and
were treated endoscopically with dextranomer/hyaluronic
acid copolymer. Three of the patients developed febrile UTIs
after surgery and underwent ureteral reimplantation. None
of these patients have had recurrent febrile UTIs. Only one
patient has had an afebrile UTI during followup. Of the 12
patients who did not have PIC-VUR, each only had 1 febrile
UTI, not recurrent UTIs, prior to cystoscopy [5].
Both of these studies further demonstrate that when a
patient with febrile UTIs, with no other clear diagnosis, is
identiﬁedashavingPIC-VURandistreated,theydonothave
recurrentfebrileUTIs.Thisreinforcestheconceptthatoccult
reﬂux identiﬁed by PIC cystography in patients with febrile
UTIs is clinically signiﬁcant and that the PIC cystogram is
an important testing modality that should be included in the
presentalgorithmoftheevaluationofpatientswithrecurrent
febrile UTIs.
6. THE REPLACEMENT OF POSTOPERATIVE VCUC
WITH PIC CYSTOGRAPHY
Pinto et al. researched the feasibility of avoiding the
need to perform a VCUG on an awake child after reﬂux
treatment by performing a PIC cystogram immediately
after endoscopic injection. Pinto found the PIC cystogram
was not useful for this purpose in a study involving 61
patients with VUR identiﬁed on VCUG. Patients underwent
dextranomer/hyaluronic acid copolymer injection followed
by PIC cystography. If the PIC cystogram was positive, no
further injection of dextranomer/hyaluronic acid copolymer
was given. The results of the PIC cystogram were compared
to the VCUG done at 3 months postoperatively. Three
ureters had positive PIC cystograms. None of these patients
were found to have VUR on postoperative VCUG. Also, 14
patientshadpersistentVURonVCUGdespiteanegativePIC
cystogram at the time of injection [6]. In addition, Palmer
has also demonstrated no correlation between intraoperative
cystographyandpostoperativeconventionalcystography[7].
Our anecdotal experience with this method shows similar
results.
Currently, there is no evidence to support the use
of PIC cystography after endoscopic injection to predict
postoperative outcomes. Therefore, it is not recommended
to replace a postoperative VCUG with a PIC cystogram at
the time of endoscopic correction of VUR.
7. PHYSICS OF PIC CYSTOGRAPHY
The impact of intravesical pressure upon the status of PIC-
VURwasexaminedfromhistoricalclinicalconsiderations,in
vitrosimulationstudy,andclinicalexamination.Historically,
it is commonly held that VUR may be induced in a
normal ureteral oriﬁce by conditions which chronically
impose supraphysiological pressure such as neuropathic or
nonneurogenic neurogenic bladder; however it is commonly
held that VUR is not able to be induced by acute application
of elevated intravesical pressure [2]. We have demonstrated
that when the PIC cystogram is performed as described
above the intravesical pressure local to the ureteral oriﬁce
pressure is physiological (<20cm water). In contrast, the
practice of hand injection of contrast is associated with a
supraphysiological pressure (>100cm water) [8].
8. CLINICAL USE AND FURTHER DIRECTIONS
Currently, there are several widely accepted explanations for
recurrent UTIs including the presence of various host and
bacterial virulence factors, as well as inadequately treated
DES. Nevertheless, it is becoming widely accepted that it is
also possible that this type of patient may have occult reﬂux,
not identiﬁed on conventional VCUG, that can allow ascent
of a lower tract infection to an upper tract infection that
is febrile in nature. If so, identiﬁcation and treatment of
this form of occult reﬂux, PIC-VUR, results in a decrease
in recurrent febrile UTIs. The PIC cystogram represents a
relatively simple objective way to identify this type of occult
VUR that may be clinically signiﬁcant.
In a recent debate on PIC cystography at the Society
of Pediatric Urology it was argued that there is little data
evaluating whether or not occult VUR identiﬁed by PIC
cystography can cause renal injury. In addition, febrile UTIs
as described in most of this research on PIC cystography,
do not necessarily equate pyelonephritis [9]. While these
observations are valid, it is important to note that while it
is unknown whether or not occult reﬂux identiﬁed with PIC
cystography results in renal scarring, the present evidence
clearly demonstrates that treatment of this occult reﬂux with
either prophylactic antibiotics or surgery decreases the rate
of recurrent febrile UTIs and its associated morbidity. Even
though many of these patients may not have signiﬁcant
renal scarring or be at risk for renal damage, the clinical
beneﬁt to these patients is extremely important. However,
it will be important to evaluate these important issues as
they relate to renal scarring in future studies. In the end,
the ability to identify a causative factor that can be treated
and reduce or eliminate future febrile infections and the
morbidity associated with them is beneﬁcial to both patients
and their families.
TomoredeﬁnitivelydeﬁnetheclinicalsigniﬁcanceofPIC
cystography,aprospectiverandomizedtrialisnowunderway
in which patients who are identiﬁed as having PIC-VUR
are being randomized into 2 study groups: observation4 Advances in Urology
(no antibiotics or surgery) and treatment (endoscopic or
open surgical correction of reﬂux) [10].
9. CONCLUSION
Many children with recurrent febrile UTIs do not demon-
strate VUR on conventional VCUG. Thus, in such children,
there is neither a treatable diagnosis nor an evidence-based
treatment plan. This scenario may become associated with
signiﬁcant morbidity such as the need for hospitalization
and renal damage. A treatable diagnosis could improve
structuring a management strategy. The current research
on PIC cystography shows that the PIC cystogram can
identify clinically signiﬁcant occult VUR. When this occult
reﬂux is treated, the incidence of recurrent febrile UTIs
is signiﬁcantly reduced. We conclude that including the
performance of PIC cystography in the present algorithm
managementofpatientswithrecurrentfebrileUTIsandnor-
mal conventional VCUGs will aid structuring an evidence-
basedtreatmentplan.Futureprospectiverandomizedstudies
are currently underway to reﬁne our understanding of
the natural history of occult reﬂux and the role that PIC
cystography has in identifying this type of reﬂux.
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